Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Trial of aripiprazole in the treatment of first-episode schizophrenia

Authors
Lee, Hwa-YoungHam, Byung-JooKang, Rhee-HunPaik, Jong-WooHahn, Sang-WooLee, Moon-SooLee, Min-Soo
Issue Date
2010
Publisher
WILEY
Keywords
aripiprazole; efficacy; first-episode schizophrenia; tolerability
Citation
PSYCHIATRY AND CLINICAL NEUROSCIENCES, v.64, no.1, pp.38 - 43
Indexed
SCIE
SCOPUS
Journal Title
PSYCHIATRY AND CLINICAL NEUROSCIENCES
Volume
64
Number
1
Start Page
38
End Page
43
URI
https://scholar.korea.ac.kr/handle/2021.sw.korea/118684
DOI
10.1111/j.1440-1819.2009.02039.x
ISSN
1323-1316
Abstract
Aims: Aripiprazole is an atypical antipsychotic indicated for the treatment of adult patients with schizophrenia. It is effective and well tolerated in patients with schizophrenia or schizoaffective disorder. The aim of the present study was to investigate therapeutic efficacy and tolerability of aripiprazole in patients with first-episode schizophrenia. Methods: Twenty-one patients meeting the DSM-IV criteria for schizophrenia were recruited. The Positive and Negative Symptom Scale (PANSS) and the Clinical Global Impressions Scale (CGI) were completed at the beginning of the study and again after 1, 2, 4, and 8 weeks of aripiprazole treatment. Side-effects were analyzed using the Udvalg for Kliniske Undersogelser Side-Effect Rating Scale. Weight was checked at each testing session, and prolactin levels were measured at baseline and after 8 weeks of aripiprazole treatment. Results: Significant benefits were observed after the first week of treatment. After 1 week of aripiprazole treatment, subscale and total scores on the PANSS had decreased significantly. This significant decrease was maintained throughout the study period. The mean score of CGI severity was also significantly different after 2 weeks of aripiprazole administration when compared to baseline score, and the significance was maintained thereafter. Weight did not significantly change after aripiprazole administration. Although mean prolactin level was decreased at 8 weeks, the difference was not significant. Conclusions: Aripiprazole is an effective and well-tolerated antipsychotic agent in patients with first-episode schizophrenia. Further investigations with larger samples are needed.
Files in This Item
There are no files associated with this item.
Appears in
Collections
Graduate School > Department of Biomedical Sciences > 1. Journal Articles
College of Medicine > Department of Medical Science > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Ham, Byung Joo photo

Ham, Byung Joo
Department of Biomedical Sciences
Read more

Altmetrics

Total Views & Downloads

BROWSE